BACKGROUND: Diagnostic criteria have recently been introduced in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), for neurobehavioral disorder associated with prenatal alcohol exposure (ND-PAE). The purpose of this study is to assess the classification of this condition using the Canadian fetal alcohol spectrum disorder (FASD) multidisciplinary diagnostic guidelines as the standard of comparison. First, classification of ND-PAE was compared with Canadian FASD diagnoses of fetal alcohol syndrome (FAS), partial FAS and alcohol-related neurodevelopmental disorder. Second, classification of ND-PAE was compared with FAS and pFAS only, a criterion for which includes facial features highly predictive of prenatal alcohol exposure and effects. METHODS: Eighty-two patients underwent multidisciplinary clinical evaluations using the Canadian FASD diagnostic guidelines between 2011 and 2015. Two clinicians independently reviewed patient files for evidence of diagnostic criteria for ND-PAE when applying an impairment cut-off level of 2 or more standard deviations below the mean, or clinically significant impairment in the absence of standardized norm-referenced measures. RESULTS: Good interrater reliability was established between clinicians (κ = 0.79). Classifications of ND-PAE and Canadian FASD diagnoses, including alcohol-related neurodevelopmental disorder, were moderately correlated (Cramer V [82] = 0.44, p < 0.01). However, ND-PAE possessed low sensitivity in FASD identification. Further, there was no correlation between ND-PAE and FAS/pFAS classifications (Cramer V [82] = 0.05, p > 0.05). INTERPRETATION: Although there is considerable overlap between both sets of criteria, ND-PAE was less likely to identify patients with FASD. Although the neurobehavioral domains assessed by ND-PAE are supported in research, its diagnostic structure restricts the identification of FASD at the impairment threshold of 2 or more standard deviations. A disconnect remains with regard to impairment thresholds between FASD, which relies on neurodevelopmental data, and ND-PAE, which relies on clinical judgment.
BACKGROUND: Diagnostic criteria have recently been introduced in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), for neurobehavioral disorder associated with prenatal alcohol exposure (ND-PAE). The purpose of this study is to assess the classification of this condition using the Canadian fetal alcohol spectrum disorder (FASD) multidisciplinary diagnostic guidelines as the standard of comparison. First, classification of ND-PAE was compared with Canadian FASD diagnoses of fetal alcohol syndrome (FAS), partial FAS and alcohol-related neurodevelopmental disorder. Second, classification of ND-PAE was compared with FAS and pFAS only, a criterion for which includes facial features highly predictive of prenatal alcohol exposure and effects. METHODS: Eighty-two patients underwent multidisciplinary clinical evaluations using the Canadian FASD diagnostic guidelines between 2011 and 2015. Two clinicians independently reviewed patient files for evidence of diagnostic criteria for ND-PAE when applying an impairment cut-off level of 2 or more standard deviations below the mean, or clinically significant impairment in the absence of standardized norm-referenced measures. RESULTS: Good interrater reliability was established between clinicians (κ = 0.79). Classifications of ND-PAE and Canadian FASD diagnoses, including alcohol-related neurodevelopmental disorder, were moderately correlated (Cramer V [82] = 0.44, p < 0.01). However, ND-PAE possessed low sensitivity in FASD identification. Further, there was no correlation between ND-PAE and FAS/pFAS classifications (Cramer V [82] = 0.05, p > 0.05). INTERPRETATION: Although there is considerable overlap between both sets of criteria, ND-PAE was less likely to identify patients with FASD. Although the neurobehavioral domains assessed by ND-PAE are supported in research, its diagnostic structure restricts the identification of FASD at the impairment threshold of 2 or more standard deviations. A disconnect remains with regard to impairment thresholds between FASD, which relies on neurodevelopmental data, and ND-PAE, which relies on clinical judgment.
Authors: Claire D Coles; Amanda R Gailey; Jennifer G Mulle; Julie A Kable; Mary Ellen Lynch; Kenneth Lyons Jones Journal: Alcohol Clin Exp Res Date: 2016-03-29 Impact factor: 3.455
Authors: Julie A Kable; Mary J O'Connor; Heather Carmichael Olson; Blair Paley; Sarah N Mattson; Sally M Anderson; Edward P Riley Journal: Child Psychiatry Hum Dev Date: 2016-04
Authors: H Eugene Hoyme; Philip A May; Wendy O Kalberg; Piyadasa Kodituwakku; J Phillip Gossage; Phyllis M Trujillo; David G Buckley; Joseph H Miller; Alfredo S Aragon; Nathaniel Khaole; Denis L Viljoen; Kenneth Lyons Jones; Luther K Robinson Journal: Pediatrics Date: 2005-01 Impact factor: 7.124
Authors: Svetlana Popova; Shannon Lange; Larry Burd; Albert E Chudley; Sterling K Clarren; Jürgen Rehm Journal: PLoS One Date: 2013-04-04 Impact factor: 3.240
Authors: Rochelle E Watkins; Elizabeth J Elliott; Amanda Wilkins; Raewyn C Mutch; James P Fitzpatrick; Janet M Payne; Colleen M O'Leary; Heather M Jones; Jane Latimer; Lorian Hayes; Jane Halliday; Heather D'Antoine; Sue Miers; Elizabeth Russell; Lucinda Burns; Anne McKenzie; Elizabeth Peadon; Maureen Carter; Carol Bower Journal: BMC Pediatr Date: 2013-10-02 Impact factor: 2.125
Authors: Julie A Kable; Claire D Coles; Jennifer E Holton; Wendy O Kalberg; Philip A May; Christina D Chambers; Gretchen Bandoli Journal: Child Psychiatry Hum Dev Date: 2022-08-30